Loading clinical trials...
Loading clinical trials...
Assess the uptake of rubidium-82 in parathyroid adenomas.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Pelletier-Galarneau
CONTACT
Lead Sponsor
Matthieu Pelletier-Galarneau, MD MSc
NCT07043010 · Hyperparathyroidism, Primary, Parathyroid Neoplasms, and more
NCT05556499 · Hyperparathyroidism, Primary, Osteoporosis, and more
NCT03091140 · Hyperparathyroidism, Primary, Parathyroidectomy
NCT00975221 · Hyperparathyroidism, Primary, Hypercalcemia
Montreal Heart Institute
Montreal, Quebec
Montreal Jewish General Hospital
Montreal, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions